Ji-Won Kwon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ji-Won Kwon has a total of 289 co-authors. Here are the top co-authors by number of shared publications:
- Soo-Jong Hong
Department of Pediatrics, Humidifier Disinfectant Health Center, National Medical Center, Seoul, Republic of Korea
37 shared publications Ju-Hee Seo
Department of Pediatrics, Dankook University Hospital, Cheonan, Korea
29 shared publications- Byoung-Ju Kim
Department of Pediatrics, Inje University Haeundae Paik Hospital, Busan, Korea
21 shared publications Hyung Young Kim
Department of Pediatrics, Pusan National University Yangsan Hospital, Yangsan, Korea
18 shared publications- Jinho Yu
Department of Pediatrics, Childhood Asthma Atopy Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
18 shared publications Eun Lee
Department of Pediatrics, Chonnam National University Hospital, Gwangju, Korea
16 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (3) , 394-404
Pet Ownership Increases the Exhaled Nitric Oxide and Asthma Severity in Children With Atopic Asthma
Song KB, et al. Allergy Asthma Immunol Res. 2025 May;17(3):394-404. https://doi.org/10.4168/aair.2025.17.3.394
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (3) , 394-404
Open AccessPet Ownership Increases the Exhaled Nitric Oxide and Asthma Severity in Children With Atopic Asthma
Song KB, et al. Allergy Asthma Immunol Res. 2025 May;17(3):394-404. https://doi.org/10.4168/aair.2025.17.3.394
- Open Access
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (1) , 47-59
Longitudinal Trajectories of Asthma and Allergic Comorbidities in the Korean Childhood Asthma Study
Yoon J, et al. Allergy Asthma Immunol Res. 2025 Jan;17(1):47-59. https://doi.org/10.4168/aair.2025.17.1.47
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (1) , 47-59
Open AccessLongitudinal Trajectories of Asthma and Allergic Comorbidities in the Korean Childhood Asthma Study
Yoon J, et al. Allergy Asthma Immunol Res. 2025 Jan;17(1):47-59. https://doi.org/10.4168/aair.2025.17.1.47
- Open Access
- 1 January 2023
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 15 (6) , 757-766
Clinical Manifestations and Genotype of Primary Ciliary Dyskinesia Diagnosed in Korea: Multicenter Study
Kim M, et al. Allergy Asthma Immunol Res. 2023 Nov;15(6):757-766. https://doi.org/10.4168/aair.2023.15.6.757
- 1 January 2023
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 15 (6) , 757-766
Open AccessClinical Manifestations and Genotype of Primary Ciliary Dyskinesia Diagnosed in Korea: Multicenter Study
Kim M, et al. Allergy Asthma Immunol Res. 2023 Nov;15(6):757-766. https://doi.org/10.4168/aair.2023.15.6.757
- 10 August 2021
- Published by Wiley in Pediatric Pulmonology
- Vol. 56 (10) , 3310-3320
Pulmonary function of healthy Korean children from three independent birth cohorts: Validation of the Global Lung Function Initiative 2012 equation
Background and Objective Global Lung Function Initiative (GLI) 2012 equations were developed to resolve the age-related disparity in interpreting spirometry results. Local validation of the equation is needed, especially in Northeast Asian children. This study evaluated the GLI equation in Korean children. Methods Spirometry indices (FEV1, FVC, FEV1/FVC, and FEF25%–75%) and clinical information were gathered from three population-based birth cohorts. Predicted GLI reference values and z scores of spirometry results were calculated for 1239 healthy children. The mean, standard deviation of z scores were compared with the expected 0 and 1. Probabilities of falling below the lower limit of normal (LLN) (z score: −1.64) were compared with the expected value 5%. GLI z scores were assessed according to low (<−2), normal (≥−2 and ≤2), and high (>2) BMI z score groups. Results Mean z scores significantly differed from 0 for FEV1/FVC in males (mean [95% confidence interval]: 0.18 [0.08, 0.27]) and forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) in females (−0.23 [−0.31, −0.15] and −0.26 [−0.36, −0.16], respectively). The standard deviation was larger than 1 for all variables in males and FVC and FEV1/FVC in females. The probability of falling below the LLN was significantly larger than 5% for FEV1 (12.13% [9.64, 14.77]), FVC (15.86% [13.06, 18.81]), and forced expiratory flow at 25%–75% of forced vital capacity (FEF25%–75%) (7.31% [5.29, 9.49]) in males and FVC (11.91% [9.40, 14.60]) in females. FEV1 and FVC z scores increased across low to high body mass index (BMI) groups, and FEV1/FVC decreased from low to high BMI groups. Conclusion GLI equations marginally differ from real-world values, which should be considered by pulmonologists in practice or research.
- 10 August 2021
- Published by Wiley in Pediatric Pulmonology
- Vol. 56 (10) , 3310-3320
Pulmonary function of healthy Korean children from three independent birth cohorts: Validation of the Global Lung Function Initiative 2012 equation
Background and Objective Global Lung Function Initiative (GLI) 2012 equations were developed to resolve the age-related disparity in interpreting spirometry results. Local validation of the equation is needed, especially in Northeast Asian children. This study evaluated the GLI equation in Korean children. Methods Spirometry indices (FEV1, FVC, FEV1/FVC, and FEF25%–75%) and clinical information were gathered from three population-based birth cohorts. Predicted GLI reference values and z scores of spirometry results were calculated for 1239 healthy children. The mean, standard deviation of z scores were compared with the expected 0 and 1. Probabilities of falling below the lower limit of normal (LLN) (z score: −1.64) were compared with the expected value 5%. GLI z scores were assessed according to low (<−2), normal (≥−2 and ≤2), and high (>2) BMI z score groups. Results Mean z scores significantly differed from 0 for FEV1/FVC in males (mean [95% confidence interval]: 0.18 [0.08, 0.27]) and forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) in females (−0.23 [−0.31, −0.15] and −0.26 [−0.36, −0.16], respectively). The standard deviation was larger than 1 for all variables in males and FVC and FEV1/FVC in females. The probability of falling below the LLN was significantly larger than 5% for FEV1 (12.13% [9.64, 14.77]), FVC (15.86% [13.06, 18.81]), and forced expiratory flow at 25%–75% of forced vital capacity (FEF25%–75%) (7.31% [5.29, 9.49]) in males and FVC (11.91% [9.40, 14.60]) in females. FEV1 and FVC z scores increased across low to high body mass index (BMI) groups, and FEV1/FVC decreased from low to high BMI groups. Conclusion GLI equations marginally differ from real-world values, which should be considered by pulmonologists in practice or research.
- Open Access
- 1 January 2021
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 13 (1) , 42-55
Heterogeneity of Childhood Asthma in Korea: Cluster Analysis of the Korean Childhood Asthma Study Cohort
Yoon J, et al. Allergy Asthma Immunol Res. 2021 Jan;13(1):42-55. https://doi.org/10.4168/aair.2021.13.1.42
- 1 January 2021
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 13 (1) , 42-55
Open AccessHeterogeneity of Childhood Asthma in Korea: Cluster Analysis of the Korean Childhood Asthma Study Cohort
Yoon J, et al. Allergy Asthma Immunol Res. 2021 Jan;13(1):42-55. https://doi.org/10.4168/aair.2021.13.1.42
- 1 November 2020
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 31 (8) , 946-953
Predicting inadequate treatment response in children with chronic spontaneous urticaria
Background We aimed to investigate the treatment response and associated factors for loss of control in children with chronic spontaneous urticaria (CSU). Methods A total of 240 CSU patients (aged 0-17 years) were enrolled in a single-center study in Korea from May 2014 to May 2019. We retrospectively reviewed the medical records and compared the duration of treatment and step of medications using the urticaria control test (UCT, range 0-16 points). Serum total immunoglobulin levels, eosinophil count, allergic sensitization, autologous serum skin test, antinuclear antibody, thyroid function test, erythrocyte sedimentation rate, and C-reactive protein were measured. The patients were divided into well-controlled (sustained UCT >= 12), partly controlled (fluctuating UCT around 12), and poorly controlled (sustained UCT <12) groups. Results Of the 240 children, 150 (62.5%) achieved well-controlled status; 74 (30.8%), partly controlled; and 16 (6.7%), poorly controlled. Longer duration (adjusted odds ratio: 1.09, 95% confidence interval: 1.05-1.13,P < .001) and higher treatment steps (5.61, 2.82-11.14,P < .001) for reaching the initial 12 points or more of UCT score, initial urticaria activity score (UAS) score (1.06, 1.03-1.09,P < .001), and food sensitization (1.88, 1.03-3.46,P = .041) were associated with inadequate treatment response. The mean duration to symptom free for 1 month without medication was 14.6 months in the well-controlled group and 22.1 months in the partly controlled group (P = .002). Conclusion Children with CSU have a good treatment response. Longer duration and higher treatment step until the initial disease control, higher initial UAS7 score, and food sensitization can predict inadequate treatment response.
- 1 November 2020
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 31 (8) , 946-953
Predicting inadequate treatment response in children with chronic spontaneous urticaria
Background We aimed to investigate the treatment response and associated factors for loss of control in children with chronic spontaneous urticaria (CSU). Methods A total of 240 CSU patients (aged 0-17 years) were enrolled in a single-center study in Korea from May 2014 to May 2019. We retrospectively reviewed the medical records and compared the duration of treatment and step of medications using the urticaria control test (UCT, range 0-16 points). Serum total immunoglobulin levels, eosinophil count, allergic sensitization, autologous serum skin test, antinuclear antibody, thyroid function test, erythrocyte sedimentation rate, and C-reactive protein were measured. The patients were divided into well-controlled (sustained UCT >= 12), partly controlled (fluctuating UCT around 12), and poorly controlled (sustained UCT <12) groups. Results Of the 240 children, 150 (62.5%) achieved well-controlled status; 74 (30.8%), partly controlled; and 16 (6.7%), poorly controlled. Longer duration (adjusted odds ratio: 1.09, 95% confidence interval: 1.05-1.13,P < .001) and higher treatment steps (5.61, 2.82-11.14,P < .001) for reaching the initial 12 points or more of UCT score, initial urticaria activity score (UAS) score (1.06, 1.03-1.09,P < .001), and food sensitization (1.88, 1.03-3.46,P = .041) were associated with inadequate treatment response. The mean duration to symptom free for 1 month without medication was 14.6 months in the well-controlled group and 22.1 months in the partly controlled group (P = .002). Conclusion Children with CSU have a good treatment response. Longer duration and higher treatment step until the initial disease control, higher initial UAS7 score, and food sensitization can predict inadequate treatment response.
- Open Access
- 1 July 2020
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
- Vol. 27 (3) , 203-208
Antineutrophil Cytoplasmic Antibodies Negative Microscopic Polyangiitis With Initial Pulmonary Manifestation
Jeong Seon Lee, M.D., Min Su Oh, M.D., Jin-Haeng Chung, M.D., Ph.D., Soyoung Lee, M.D., Ph.D., Ji-Won Kwon, M.D., Ph.D.. J Rheum Dis 2020;27:203-8. https://doi.org/10.4078/jrd.2020.27.3.203
- 1 July 2020
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
- Vol. 27 (3) , 203-208
Open AccessAntineutrophil Cytoplasmic Antibodies Negative Microscopic Polyangiitis With Initial Pulmonary Manifestation
Jeong Seon Lee, M.D., Min Su Oh, M.D., Jin-Haeng Chung, M.D., Ph.D., Soyoung Lee, M.D., Ph.D., Ji-Won Kwon, M.D., Ph.D.. J Rheum Dis 2020;27:203-8. https://doi.org/10.4078/jrd.2020.27.3.203
- Open Access
- 15 January 2020
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 63 (1) , 3-7
High-flow nasal cannula oxygen therapy in children: a clinical review
High-flow nasal cannula (HFNC) is a relatively safe and effective noninvasive ventilation method that was recently accepted as a treatment option for acute respiratory support before endotracheal intubation or invasive ventilation. The action mechanism of HFNC includes a decrease in nasopharyngeal resistance, washout of dead space, reduction in inflow of ambient air, and an increase in airway pressure. In preterm infants, HFNC can be used to prevent reintubation and initial noninvasive respiratory support after birth. In children, flow level adjustments are crucial considering their maximal efficacy and complications. Randomized controlled studies suggest that HFNC can be used in cases of moderate to severe bronchiolitis upon initial low-flow oxygen failure. HFNC can also reduce intubation and mechanical ventilation in children with respiratory failure. Several observational studies have shown that HFNC can be beneficial in acute asthma and other respiratory distress. Multicenter randomized studies are warranted to determine the feasibility and adherence of HFNC and continuous positive airway pressure in pediatric intensive care units. The development of clinical guidelines for HFNC, including flow settings, indications, and contraindications, device management, efficacy identification, and safety issues are needed, particularly in children.
- 15 January 2020
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 63 (1) , 3-7
Open AccessHigh-flow nasal cannula oxygen therapy in children: a clinical review
High-flow nasal cannula (HFNC) is a relatively safe and effective noninvasive ventilation method that was recently accepted as a treatment option for acute respiratory support before endotracheal intubation or invasive ventilation. The action mechanism of HFNC includes a decrease in nasopharyngeal resistance, washout of dead space, reduction in inflow of ambient air, and an increase in airway pressure. In preterm infants, HFNC can be used to prevent reintubation and initial noninvasive respiratory support after birth. In children, flow level adjustments are crucial considering their maximal efficacy and complications. Randomized controlled studies suggest that HFNC can be used in cases of moderate to severe bronchiolitis upon initial low-flow oxygen failure. HFNC can also reduce intubation and mechanical ventilation in children with respiratory failure. Several observational studies have shown that HFNC can be beneficial in acute asthma and other respiratory distress. Multicenter randomized studies are warranted to determine the feasibility and adherence of HFNC and continuous positive airway pressure in pediatric intensive care units. The development of clinical guidelines for HFNC, including flow settings, indications, and contraindications, device management, efficacy identification, and safety issues are needed, particularly in children.
- Open Access
- 1 January 2020
- Published by The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al in Allergy Asthma & Respiratory Disease
- Vol. 8 (4) , 191-198
Risk factors for the development of asthma symptoms in children with allergic rhinitis
박유미, et al. Allergy Asthma Respir Dis. 2020 Oct;8(4):191-198. https://doi.org/10.4168/aard.2020.8.4.191
- 1 January 2020
- Published by The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al in Allergy Asthma & Respiratory Disease
- Vol. 8 (4) , 191-198
Open AccessRisk factors for the development of asthma symptoms in children with allergic rhinitis
박유미, et al. Allergy Asthma Respir Dis. 2020 Oct;8(4):191-198. https://doi.org/10.4168/aard.2020.8.4.191
- Open Access
- 1 January 2020
- Published by The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al in Allergy, Asthma & Immunology Research
- Vol. 12 (1) , 72-85
Risk Factors and Comorbidities Associated With the Allergic Rhinitis Phenotype in Children According to the ARIA Classification
Purpose: Data are lacking on the association between the allergic rhinitis (AR) phenotype and sensitization to specific allergens or bronchial hyperresponsiveness (BHR) in children. We here investigated risk factors and comorbidities, including sensitization to specific allergens and BHR, for the AR phenotype by AR and its Impact on Asthma (ARIA) classification in a general population-based birth cohort study. Methods: We enrolled 606 children aged 7 years from the Panel Study of Korean Children. The AR phenotype was assigned in accordance with the ARIA classification in children. Skin prick tests and Provocholine provocation test were performed. Risk factors and comorbidities for AR phenotypes were then analyzed. Results: The prevalence of mild and moderate to severe AR in our study cohort was 37.2% and 8.8%, respectively. Recent use of analgesics or antipyretics and current cat ownership were associated with the risk of mild persistent AR. Sensitizations to Dermatophagoides Pteronyssinus (Der p), Japanese hop and cat were associated with moderate to severe persistent AR. Children with moderate to severe AR had a higher risk of current asthma and BHR compared to mild AR cases (adjusted odds ratio (aOR), 5.26; 95% confidence interval [CI], 1.77-15.62). Moderate to severe AR with allergic sensitization was associated with the highest risk of BHR (aOR, 11.77; 95% CI, 3.40-40.74). Conclusions: Moderate to severe-persistent AR is more closely related to respiratory comorbidities and sensitizations than mild AR. Stratifying the AR phenotype by ARIA classification may assist in disease management.
- 1 January 2020
- Published by The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al in Allergy, Asthma & Immunology Research
- Vol. 12 (1) , 72-85
Open AccessRisk Factors and Comorbidities Associated With the Allergic Rhinitis Phenotype in Children According to the ARIA Classification
Purpose: Data are lacking on the association between the allergic rhinitis (AR) phenotype and sensitization to specific allergens or bronchial hyperresponsiveness (BHR) in children. We here investigated risk factors and comorbidities, including sensitization to specific allergens and BHR, for the AR phenotype by AR and its Impact on Asthma (ARIA) classification in a general population-based birth cohort study. Methods: We enrolled 606 children aged 7 years from the Panel Study of Korean Children. The AR phenotype was assigned in accordance with the ARIA classification in children. Skin prick tests and Provocholine provocation test were performed. Risk factors and comorbidities for AR phenotypes were then analyzed. Results: The prevalence of mild and moderate to severe AR in our study cohort was 37.2% and 8.8%, respectively. Recent use of analgesics or antipyretics and current cat ownership were associated with the risk of mild persistent AR. Sensitizations to Dermatophagoides Pteronyssinus (Der p), Japanese hop and cat were associated with moderate to severe persistent AR. Children with moderate to severe AR had a higher risk of current asthma and BHR compared to mild AR cases (adjusted odds ratio (aOR), 5.26; 95% confidence interval [CI], 1.77-15.62). Moderate to severe AR with allergic sensitization was associated with the highest risk of BHR (aOR, 11.77; 95% CI, 3.40-40.74). Conclusions: Moderate to severe-persistent AR is more closely related to respiratory comorbidities and sensitizations than mild AR. Stratifying the AR phenotype by ARIA classification may assist in disease management.